BeiGene Ltd. - Bathi mangsa ngarep BGNE

BGNE (BeiGene Ltd.) - tandha merek perusahaan

BeiGene, Ltd. (BGNE) management relies on autonomous development cycles that remain independent of external crises. The future profit trajectory clearly demonstrates the results of this strategy. Financial stability is based on global sales of patent-protected drugs, while the environmental vector is implemented through the adoption of "green chemistry." Meanwhile, the 1.11 indicator reflects the current status of the issuer's revenue expectations.

BGNE: Bathi mangsa ngarep beigene.com 27.02.2025 - 18.11.2026

BeOne Medicines - rincian analitis lan metrik utama (BGNE)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:BeiGene, BGNE
Barang utama BeiGene Ltd.

This indicator reflects the dynamics of revised market expectations for net profit, eliminating the time lag between official reports. For BeiGene, Ltd. (BGNE), the calculation is based on the expansion rates of the drug Brukinsa and incoming partner royalty streams. By analyzing the estimated future profit chart on GURU.Markets, an investor can see the current fundamental value of the asset. This allows for the timely recognition of a shift in yield trends. Precise monitoring of the curve ensures capital stability within the volatile biotech sector.

Pesaing wigati

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Bathi resik sing dikarepake|PPBT: Bathi mangsa ngarep|Penghasilan resik sing dikarepake AONC (American Oncology Network, Inc.)|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake